ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0611

Disease Activity and Disability Are Not Associated with Rehabilitation Utilization in African Americans with Rheumatoid Arthritis

Louise Thoma1, Rebecca Cleveland2, S. Louis Bridges3, Beth Jonas1 and Leigh Callahan4, 1University of North Carolina at Chapel Hill, Chapel Hill, NC, 2University of North Carolina, Chapel Hill, NC, 3University of Alabama at Birmingham, Mountain Brk, AL, 4University of North Carolina Thurston Arthritis Research Center, Chapel Hill, NC

Meeting: ACR Convergence 2020

Keywords: Rehabilitation, rheumatoid arthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 7, 2020

Title: Health Services Research Poster

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Considerable advances in pharmacological care for adults with rheumatoid arthritis (RA) over the last 25 years have reduced disease activity in individual patients, but disability has not improved to the same extent. Rehabilitation, including physical therapy (PT) and occupational therapy (OT), is recommended to address disability and functional limitations, yet utilization of rehabilitation for adults with RA in the United States is low. Reductions in RA disease activity and disability are associated with utilization of rehabilitation services in Caucasian adults with RA, but it is unclear if associations are similar in African Americans. Thus, we examined the association of disease activity and disability with rehabilitation utilization in African Americans with RA.

Methods: We analyzed baseline data from the Consortium for the Longitudinal Evaluation of African Americans with RA (CLEAR) I Registry (disease duration < 24 months) and the CLEAR II Registry (any disease duration). Data were collected in a single visit for each participant at one of four southeastern US institutions. The clinical variables of interest were disease activity, defined by the Disease Activity Score 28 with C-Reactive Protein (DAS28-CRP), and disability, measured with the Health Assessment Questionnaire (HAQ). Rehabilitation utilization variables were self-reported recall of PT or OT in the prior 6 months (yes/no) and any prior PT or OT utilization (yes/no). We examined the association of disease activity and disability with rehabilitation utilization using separate binary logistic regression models to estimate odds ratios and 95% confidence intervals. We adjusted for age (years), sex, body mass index (BMI, kg/m2), disease duration (months), use of disease modifying anti-rheumatic drugs (DMARD; yes/no), comorbidities (number), household income ( >$30k vs. ≤$30k), and education (more than high school vs. high school grad or less). We repeated the analyses with the sample stratified by disease duration: early RA and established RA.

Results: Of 1067 participants, 14% reported utilizing rehabilitation in the prior 6 months, and 41% reported ever utilizing rehabilitation (Table 1). Rehabilitation utilization in the prior 6 months was similar among those with early and established RA (13% vs. 15%), but a greater proportion of those with established RA reported any past rehabilitation utilization (31% vs. 48%). Disease activity and disability at the time of baseline visit were not associated with rehabilitation utilization in the past 6 months or ever, in unadjusted and adjusted models (Table 2).

Conclusion: Among African Americans with RA, rehabilitation utilization was low (14%) in the 6 months prior to enrollment into CLEAR, and was not associated with disease activity or disability level. Factors driving rehabilitation utilization in African Americans with RA, as well as success in reducing disease activity and disability, are unclear, and should be a focus of future research to facilitate delivery of appropriate and effective rehabilitation services.

Table 1. Participant Characteristics

Table 2. Association of disease activity and disability with rehabilitation utilization


Disclosure: L. Thoma, None; R. Cleveland, None; S. Bridges, None; B. Jonas, None; L. Callahan, Gilead, 5.

To cite this abstract in AMA style:

Thoma L, Cleveland R, Bridges S, Jonas B, Callahan L. Disease Activity and Disability Are Not Associated with Rehabilitation Utilization in African Americans with Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/disease-activity-and-disability-are-not-associated-with-rehabilitation-utilization-in-african-americans-with-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/disease-activity-and-disability-are-not-associated-with-rehabilitation-utilization-in-african-americans-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology